L-buthionine sulfoximine encapsulated hollow calcium peroxide as a chloroperoxidase nanocarrier for enhanced enzyme dynamic therapy

Bin Liu, Yulong Bian, Meng Yuan, Yanlin Zhu, Shikai Liu, He Ding, Shili Gai, Piaoping Yang, Ziyong Cheng, Jun Lin

Journal:BIOMATERIALS

IF:15.3

DOI:10.1016/j.biomaterials.2022.121746

PMID:36084482

Published:2022-09-02

research field:生物医学工程免疫治疗再生医学纳米医学肝病学

Abstract

The appropriate design of multifunctional nanocarriers for chloroperoxidase (CPO) delivery and the simultaneous improvement of the efficiency of enzyme dynamic therapy (EDT) remain significant challenges. Herein, we report a facile one-step route to obtain a multifunctional nanocarrier for the formation of sodium hyaluronate-modified hollow calcium peroxide spheres with encapsulated L-buthionine sulfoximine (BSO), followed by delivery of CPO for enhanced EDT. After effective accumulation at the tumor sites, the nanocomposite rapidly decomposes and releases Ca 2+ , BSO molecules, CPO, and concurrently generates a large volume of hydrogen peroxide (H 2 O 2 ) in the endogenous tumor microenvironment (TME). BSO molecules inhibit the biosynthesis of glutathione (GSH) by inactivating γ-glutamyl cysteine synthetase. Due to BSO-induced GSH depletion and self-supply of H 2 O 2 , the EDT efficiency of CPO was significantly enhanced to achieve high tumor therapy efficiency. Additionally, overloaded Ca 2+ caused mitochondrial damage and amplified the oxidative stress . Moreover, calcification resulted from the unbalanced calcium transport channel caused by enhanced oxidative stress, accelerating tumor apoptosis and improving the efficacy of computed tomography (CT) imaging visual tumor therapy. This simple and efficient design for multifunctional nanocomposites will likely take an important place in the field of combined tumor therapeutics.

本文使用的Yeasen产品

购物车
客服
转染试用